Report cover image

Global Botanical Drug Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 194 Pages
SKU # APRC20361101

Description

Summary

According to APO Research, The global Botanical Drug market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Botanical Drug is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Botanical Drug is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Botanical Drug is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Botanical Drug is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Botanical Drug include Yunnan Baiyao, Tong Ren Tang, Buchang Pharmaceuticals, Guangzhou Baiyunshan Pharmaceutical, Weleda, Tsumura, Tasly Holding Group, Taiji and Schwabe, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Botanical Drug, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Botanical Drug, also provides the revenue of main regions and countries. Of the upcoming market potential for Botanical Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Botanical Drug revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Botanical Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Botanical Drug revenue, projected growth trends, production technology, application and end-user industry.

Botanical Drug Segment by Company

Yunnan Baiyao
Tong Ren Tang
Buchang Pharmaceuticals
Guangzhou Baiyunshan Pharmaceutical
Weleda
Tsumura
Tasly Holding Group
Taiji
Schwabe
Kwangdong
Jumpcan Pharmaceutical
Huarun 999
GW Pharmaceuticals
China TCM
Bionorica Se
Botanical Drug Segment by Type

Prescription Drug
OTC
Botanical Drug Segment by Application

Tumor
Cardiovascular
Respiratory System
Other
Botanical Drug Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Botanical Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Botanical Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Botanical Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Botanical Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Botanical Drug company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Botanical Drug revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.

Table of Contents

194 Pages
1 Market Overview
1.1 Product Definition
1.2 Botanical Drug Market by Type
1.2.1 Global Botanical Drug Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Prescription Drug
1.2.3 OTC
1.3 Botanical Drug Market by Application
1.3.1 Global Botanical Drug Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Tumor
1.3.3 Cardiovascular
1.3.4 Respiratory System
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Botanical Drug Market Dynamics
2.1 Botanical Drug Industry Trends
2.2 Botanical Drug Industry Drivers
2.3 Botanical Drug Industry Opportunities and Challenges
2.4 Botanical Drug Industry Restraints
3 Global Growth Perspective
3.1 Global Botanical Drug Market Perspective (2020-2031)
3.2 Global Botanical Drug Growth Trends by Region
3.2.1 Global Botanical Drug Market Size by Region: 2020 VS 2024 VS 2031
3.2.2 Global Botanical Drug Market Size by Region (2020-2025)
3.2.3 Global Botanical Drug Market Size by Region (2026-2031)
4 Competitive Landscape by Players
4.1 Global Botanical Drug Revenue by Players
4.1.1 Global Botanical Drug Revenue by Players (2020-2025)
4.1.2 Global Botanical Drug Revenue Market Share by Players (2020-2025)
4.1.3 Global Botanical Drug Players Revenue Share Top 10 and Top 5 in 2024
4.2 Global Botanical Drug Key Players Ranking, 2023 VS 2024 VS 2025
4.3 Global Botanical Drug Key Players Headquarters & Area Served
4.4 Global Botanical Drug Players, Product Type & Application
4.5 Global Botanical Drug Players Establishment Date
4.6 Market Competitive Analysis
4.6.1 Global Botanical Drug Market CR5 and HHI
4.6.3 2024 Botanical Drug Tier 1, Tier 2, and Tier 3
5 Botanical Drug Market Size by Type
5.1 Global Botanical Drug Revenue by Type (2020 VS 2024 VS 2031)
5.2 Global Botanical Drug Revenue by Type (2020-2031)
5.3 Global Botanical Drug Revenue Market Share by Type (2020-2031)
6 Botanical Drug Market Size by Application
6.1 Global Botanical Drug Revenue by Application (2020 VS 2024 VS 2031)
6.2 Global Botanical Drug Revenue by Application (2020-2031)
6.3 Global Botanical Drug Revenue Market Share by Application (2020-2031)
7 Company Profiles
7.1 Yunnan Baiyao
7.1.1 Yunnan Baiyao Comapny Information
7.1.2 Yunnan Baiyao Business Overview
7.1.3 Yunnan Baiyao Botanical Drug Revenue and Gross Margin (2020-2025)
7.1.4 Yunnan Baiyao Botanical Drug Product Portfolio
7.1.5 Yunnan Baiyao Recent Developments
7.2 Tong Ren Tang
7.2.1 Tong Ren Tang Comapny Information
7.2.2 Tong Ren Tang Business Overview
7.2.3 Tong Ren Tang Botanical Drug Revenue and Gross Margin (2020-2025)
7.2.4 Tong Ren Tang Botanical Drug Product Portfolio
7.2.5 Tong Ren Tang Recent Developments
7.3 Buchang Pharmaceuticals
7.3.1 Buchang Pharmaceuticals Comapny Information
7.3.2 Buchang Pharmaceuticals Business Overview
7.3.3 Buchang Pharmaceuticals Botanical Drug Revenue and Gross Margin (2020-2025)
7.3.4 Buchang Pharmaceuticals Botanical Drug Product Portfolio
7.3.5 Buchang Pharmaceuticals Recent Developments
7.4 Guangzhou Baiyunshan Pharmaceutical
7.4.1 Guangzhou Baiyunshan Pharmaceutical Comapny Information
7.4.2 Guangzhou Baiyunshan Pharmaceutical Business Overview
7.4.3 Guangzhou Baiyunshan Pharmaceutical Botanical Drug Revenue and Gross Margin (2020-2025)
7.4.4 Guangzhou Baiyunshan Pharmaceutical Botanical Drug Product Portfolio
7.4.5 Guangzhou Baiyunshan Pharmaceutical Recent Developments
7.5 Weleda
7.5.1 Weleda Comapny Information
7.5.2 Weleda Business Overview
7.5.3 Weleda Botanical Drug Revenue and Gross Margin (2020-2025)
7.5.4 Weleda Botanical Drug Product Portfolio
7.5.5 Weleda Recent Developments
7.6 Tsumura
7.6.1 Tsumura Comapny Information
7.6.2 Tsumura Business Overview
7.6.3 Tsumura Botanical Drug Revenue and Gross Margin (2020-2025)
7.6.4 Tsumura Botanical Drug Product Portfolio
7.6.5 Tsumura Recent Developments
7.7 Tasly Holding Group
7.7.1 Tasly Holding Group Comapny Information
7.7.2 Tasly Holding Group Business Overview
7.7.3 Tasly Holding Group Botanical Drug Revenue and Gross Margin (2020-2025)
7.7.4 Tasly Holding Group Botanical Drug Product Portfolio
7.7.5 Tasly Holding Group Recent Developments
7.8 Taiji
7.8.1 Taiji Comapny Information
7.8.2 Taiji Business Overview
7.8.3 Taiji Botanical Drug Revenue and Gross Margin (2020-2025)
7.8.4 Taiji Botanical Drug Product Portfolio
7.8.5 Taiji Recent Developments
7.9 Schwabe
7.9.1 Schwabe Comapny Information
7.9.2 Schwabe Business Overview
7.9.3 Schwabe Botanical Drug Revenue and Gross Margin (2020-2025)
7.9.4 Schwabe Botanical Drug Product Portfolio
7.9.5 Schwabe Recent Developments
7.10 Kwangdong
7.10.1 Kwangdong Comapny Information
7.10.2 Kwangdong Business Overview
7.10.3 Kwangdong Botanical Drug Revenue and Gross Margin (2020-2025)
7.10.4 Kwangdong Botanical Drug Product Portfolio
7.10.5 Kwangdong Recent Developments
7.11 Jumpcan Pharmaceutical
7.11.1 Jumpcan Pharmaceutical Comapny Information
7.11.2 Jumpcan Pharmaceutical Business Overview
7.11.3 Jumpcan Pharmaceutical Botanical Drug Revenue and Gross Margin (2020-2025)
7.11.4 Jumpcan Pharmaceutical Botanical Drug Product Portfolio
7.11.5 Jumpcan Pharmaceutical Recent Developments
7.12 Huarun 999
7.12.1 Huarun 999 Comapny Information
7.12.2 Huarun 999 Business Overview
7.12.3 Huarun 999 Botanical Drug Revenue and Gross Margin (2020-2025)
7.12.4 Huarun 999 Botanical Drug Product Portfolio
7.12.5 Huarun 999 Recent Developments
7.13 GW Pharmaceuticals
7.13.1 GW Pharmaceuticals Comapny Information
7.13.2 GW Pharmaceuticals Business Overview
7.13.3 GW Pharmaceuticals Botanical Drug Revenue and Gross Margin (2020-2025)
7.13.4 GW Pharmaceuticals Botanical Drug Product Portfolio
7.13.5 GW Pharmaceuticals Recent Developments
7.14 China TCM
7.14.1 China TCM Comapny Information
7.14.2 China TCM Business Overview
7.14.3 China TCM Botanical Drug Revenue and Gross Margin (2020-2025)
7.14.4 China TCM Botanical Drug Product Portfolio
7.14.5 China TCM Recent Developments
7.15 Bionorica Se
7.15.1 Bionorica Se Comapny Information
7.15.2 Bionorica Se Business Overview
7.15.3 Bionorica Se Botanical Drug Revenue and Gross Margin (2020-2025)
7.15.4 Bionorica Se Botanical Drug Product Portfolio
7.15.5 Bionorica Se Recent Developments
8 North America
8.1 North America Botanical Drug Revenue (2020-2031)
8.2 North America Botanical Drug Revenue by Type (2020-2031)
8.2.1 North America Botanical Drug Revenue by Type (2020-2025)
8.2.2 North America Botanical Drug Revenue by Type (2026-2031)
8.3 North America Botanical Drug Revenue Share by Type (2020-2031)
8.4 North America Botanical Drug Revenue by Application (2020-2031)
8.4.1 North America Botanical Drug Revenue by Application (2020-2025)
8.4.2 North America Botanical Drug Revenue by Application (2026-2031)
8.5 North America Botanical Drug Revenue Share by Application (2020-2031)
8.6 North America Botanical Drug Revenue by Country
8.6.1 North America Botanical Drug Revenue by Country (2020 VS 2024 VS 2031)
8.6.2 North America Botanical Drug Revenue by Country (2020-2025)
8.6.3 North America Botanical Drug Revenue by Country (2026-2031)
8.6.4 United States
8.6.5 Canada
9 Europe
9.1 Europe Botanical Drug Revenue (2020-2031)
9.2 Europe Botanical Drug Revenue by Type (2020-2031)
9.2.1 Europe Botanical Drug Revenue by Type (2020-2025)
9.2.2 Europe Botanical Drug Revenue by Type (2026-2031)
9.3 Europe Botanical Drug Revenue Share by Type (2020-2031)
9.4 Europe Botanical Drug Revenue by Application (2020-2031)
9.4.1 Europe Botanical Drug Revenue by Application (2020-2025)
9.4.2 Europe Botanical Drug Revenue by Application (2026-2031)
9.5 Europe Botanical Drug Revenue Share by Application (2020-2031)
9.6 Europe Botanical Drug Revenue by Country
9.6.1 Europe Botanical Drug Revenue by Country (2020 VS 2024 VS 2031)
9.6.2 Europe Botanical Drug Revenue by Country (2020-2025)
9.6.3 Europe Botanical Drug Revenue by Country (2026-2031)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Netherlands
9.6.9 Nordic Countries
10 China
10.1 China Botanical Drug Revenue (2020-2031)
10.2 China Botanical Drug Revenue by Type (2020-2031)
10.2.1 China Botanical Drug Revenue by Type (2020-2025)
10.2.2 China Botanical Drug Revenue by Type (2026-2031)
10.3 China Botanical Drug Revenue Share by Type (2020-2031)
10.4 China Botanical Drug Revenue by Application (2020-2031)
10.4.1 China Botanical Drug Revenue by Application (2020-2025)
10.4.2 China Botanical Drug Revenue by Application (2026-2031)
10.5 China Botanical Drug Revenue Share by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Botanical Drug Revenue (2020-2031)
11.2 Asia Botanical Drug Revenue by Type (2020-2031)
11.2.1 Asia Botanical Drug Revenue by Type (2020-2025)
11.2.2 Asia Botanical Drug Revenue by Type (2026-2031)
11.3 Asia Botanical Drug Revenue Share by Type (2020-2031)
11.4 Asia Botanical Drug Revenue by Application (2020-2031)
11.4.1 Asia Botanical Drug Revenue by Application (2020-2025)
11.4.2 Asia Botanical Drug Revenue by Application (2026-2031)
11.5 Asia Botanical Drug Revenue Share by Application (2020-2031)
11.6 Asia Botanical Drug Revenue by Country
11.6.1 Asia Botanical Drug Revenue by Country (2020 VS 2024 VS 2031)
11.6.2 Asia Botanical Drug Revenue by Country (2020-2025)
11.6.3 Asia Botanical Drug Revenue by Country (2026-2031)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 Taiwan
11.6.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Botanical Drug Revenue (2020-2031)
12.2 SAMEA Botanical Drug Revenue by Type (2020-2031)
12.2.1 SAMEA Botanical Drug Revenue by Type (2020-2025)
12.2.2 SAMEA Botanical Drug Revenue by Type (2026-2031)
12.3 SAMEA Botanical Drug Revenue Share by Type (2020-2031)
12.4 SAMEA Botanical Drug Revenue by Application (2020-2031)
12.4.1 SAMEA Botanical Drug Revenue by Application (2020-2025)
12.4.2 SAMEA Botanical Drug Revenue by Application (2026-2031)
12.5 SAMEA Botanical Drug Revenue Share by Application (2020-2031)
12.6 SAMEA Botanical Drug Revenue by Country
12.6.1 SAMEA Botanical Drug Revenue by Country (2020 VS 2024 VS 2031)
12.6.2 SAMEA Botanical Drug Revenue by Country (2020-2025)
12.6.3 SAMEA Botanical Drug Revenue by Country (2026-2031)
12.6.4 Brazil
12.6.5 Argentina
12.6.6 Chile
12.6.7 Colombia
12.6.8 Peru
12.6.9 Saudi Arabia
12.6.10 Israel
12.6.11 UAE
12.6.12 Turkey
12.6.13 Iran
12.6.14 Egypt
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.